Design, synthesis, and structure–activity relationships of indole-3-heterocycles as agonists of the CB1 receptor

Novel indole-3-heterocycles were designed and synthesized and found to be potent CB1 receptor agonists. Starting from a microsomally unstable lead 1, a bioisostere approach replacing a piperazine amide was undertaken. This was found to be a good strategy for improving stability both in vitro and in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic & medicinal chemistry letters 2011-01, Vol.21 (1), p.506-509
Hauptverfasser: Morrison, Angus J., Adam, Julia M., Baker, James A., Campbell, Robert A., Clark, John K., Cottney, Jean E., Deehan, Maureen, Easson, Anna-Marie, Fields, Ruth, Francis, Stuart, Jeremiah, Fiona, Keddie, Neil, Kiyoi, Takao, McArthur, Duncan R., Meyer, Karsten, Ratcliffe, Paul D., Schulz, Jurgen, Wishart, Grant, Yoshiizumi, Kazuya
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Novel indole-3-heterocycles were designed and synthesized and found to be potent CB1 receptor agonists. Starting from a microsomally unstable lead 1, a bioisostere approach replacing a piperazine amide was undertaken. This was found to be a good strategy for improving stability both in vitro and in vivo. This led to the discovery of 24, which had an increased duration of action in the mouse tail flick test in comparison to the lead 1.
ISSN:0960-894X
1464-3405
DOI:10.1016/j.bmcl.2010.10.093